RSBN1L | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	29 studies	23% ± 6%	Explore
natural killer cell	29 studies	25% ± 6%	Explore
CD8-positive, alpha-beta T cell	23 studies	22% ± 7%	Explore
smooth muscle cell	21 studies	21% ± 4%	Explore
CD4-positive, alpha-beta T cell	19 studies	20% ± 5%	Explore
fibroblast	19 studies	22% ± 5%	Explore
endothelial cell	19 studies	28% ± 12%	Explore
T cell	18 studies	21% ± 5%	Explore
regulatory T cell	18 studies	24% ± 6%	Explore
pericyte	17 studies	22% ± 5%	Explore
naive B cell	16 studies	22% ± 4%	Explore
memory B cell	15 studies	20% ± 3%	Explore
gamma-delta T cell	15 studies	24% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	25% ± 6%	Explore
ciliated cell	14 studies	24% ± 10%	Explore
CD16-negative, CD56-bright natural killer cell, human	14 studies	21% ± 5%	Explore
basal cell	12 studies	27% ± 13%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	12 studies	21% ± 5%	Explore
mature NK T cell	12 studies	23% ± 5%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	22% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	11 studies	23% ± 7%	Explore
oligodendrocyte precursor cell	11 studies	30% ± 14%	Explore
mast cell	10 studies	21% ± 7%	Explore
type I pneumocyte	10 studies	28% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	10 studies	24% ± 5%	Explore
mucosal invariant T cell	10 studies	19% ± 3%	Explore
macrophage	10 studies	25% ± 7%	Explore
astrocyte	10 studies	30% ± 12%	Explore
oligodendrocyte	10 studies	28% ± 10%	Explore
club cell	9 studies	21% ± 8%	Explore
myofibroblast cell	9 studies	23% ± 5%	Explore
glutamatergic neuron	9 studies	39% ± 23%	Explore
epithelial cell	9 studies	36% ± 18%	Explore
CD4-positive, alpha-beta memory T cell	8 studies	20% ± 4%	Explore
abnormal cell	8 studies	21% ± 8%	Explore
neuron	8 studies	35% ± 15%	Explore
amacrine cell	8 studies	37% ± 12%	Explore
retinal rod cell	8 studies	39% ± 4%	Explore
microglial cell	8 studies	25% ± 7%	Explore
type II pneumocyte	8 studies	24% ± 7%	Explore
connective tissue cell	7 studies	22% ± 5%	Explore
interneuron	7 studies	37% ± 21%	Explore
retinal cone cell	7 studies	41% ± 13%	Explore
GABAergic neuron	7 studies	43% ± 18%	Explore
non-classical monocyte	6 studies	22% ± 7%	Explore
plasma cell	6 studies	29% ± 10%	Explore
retina horizontal cell	6 studies	38% ± 12%	Explore
T follicular helper cell	6 studies	20% ± 2%	Explore
monocyte	6 studies	21% ± 4%	Explore
goblet cell	6 studies	30% ± 11%	Explore
plasmacytoid dendritic cell	6 studies	24% ± 6%	Explore
respiratory goblet cell	5 studies	26% ± 5%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	23% ± 5%	Explore
leukocyte	5 studies	25% ± 2%	Explore
retinal bipolar neuron	5 studies	40% ± 13%	Explore
lymphocyte	5 studies	29% ± 9%	Explore
precursor B cell	5 studies	30% ± 11%	Explore
myeloid cell	5 studies	23% ± 7%	Explore
dendritic cell	5 studies	30% ± 14%	Explore
Mueller cell	5 studies	25% ± 5%	Explore
endothelial cell of lymphatic vessel	5 studies	22% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	19% ± 2%	Explore
secretory cell	4 studies	27% ± 7%	Explore
classical monocyte	4 studies	25% ± 5%	Explore
conventional dendritic cell	4 studies	28% ± 14%	Explore
exhausted T cell	4 studies	30% ± 10%	Explore
hematopoietic precursor cell	4 studies	31% ± 10%	Explore
progenitor cell	4 studies	21% ± 3%	Explore
retinal ganglion cell	4 studies	32% ± 11%	Explore
immature B cell	4 studies	27% ± 6%	Explore
cardiac muscle cell	4 studies	21% ± 3%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	22% ± 4%	Explore
innate lymphoid cell	4 studies	22% ± 4%	Explore
brush cell	4 studies	21% ± 5%	Explore
plasmablast	3 studies	35% ± 13%	Explore
capillary endothelial cell	3 studies	17% ± 3%	Explore
neural crest cell	3 studies	18% ± 2%	Explore
GABAergic interneuron	3 studies	21% ± 3%	Explore
glial cell	3 studies	25% ± 11%	Explore
granule cell	3 studies	24% ± 9%	Explore
pro-B cell	3 studies	31% ± 6%	Explore
adipocyte	3 studies	21% ± 4%	Explore
GABAergic amacrine cell	3 studies	31% ± 7%	Explore
OFF-bipolar cell	3 studies	33% ± 6%	Explore
ON-bipolar cell	3 studies	43% ± 12%	Explore
glycinergic amacrine cell	3 studies	29% ± 3%	Explore
rod bipolar cell	3 studies	50% ± 5%	Explore
endothelial cell of vascular tree	3 studies	25% ± 3%	Explore
CD4-positive helper T cell	3 studies	19% ± 3%	Explore
neural progenitor cell	3 studies	29% ± 8%	Explore
enteroendocrine cell	3 studies	27% ± 7%	Explore
intestinal crypt stem cell	3 studies	19% ± 3%	Explore
alveolar macrophage	3 studies	22% ± 6%	Explore
group 3 innate lymphoid cell	3 studies	28% ± 10%	Explore
transit amplifying cell	3 studies	35% ± 24%	Explore
double negative thymocyte	3 studies	31% ± 15%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	13 studies	21% ± 6%	Explore
brain	13 studies	33% ± 17%	Explore
peripheral blood	9 studies	24% ± 7%	Explore
eye	9 studies	37% ± 8%	Explore
intestine	6 studies	21% ± 8%	Explore
lymph node	5 studies	19% ± 1%	Explore
liver	4 studies	34% ± 9%	Explore
adipose	4 studies	21% ± 2%	Explore
kidney	3 studies	23% ± 5%	Explore
bone marrow	3 studies	18% ± 2%	Explore
heart	3 studies	19% ± 1%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	1994.99	1445 / 1445	100%	19.01	183 / 183
intestine	100%	2287.64	966 / 966	100%	15.29	527 / 527
ovary	100%	2199.15	180 / 180	100%	16.84	430 / 430
stomach	100%	1575.48	359 / 359	100%	16.64	286 / 286
breast	100%	1813.50	459 / 459	100%	22.76	1117 / 1118
lung	100%	1775.45	577 / 578	100%	19.87	1155 / 1155
brain	100%	1393.27	2637 / 2642	100%	18.83	705 / 705
prostate	100%	1901.84	245 / 245	100%	13.91	501 / 502
uterus	100%	2386.82	170 / 170	100%	15.70	458 / 459
thymus	100%	2397.08	653 / 653	100%	19.90	603 / 605
bladder	100%	2311.29	21 / 21	100%	13.95	502 / 504
pancreas	100%	1164.20	328 / 328	99%	13.85	177 / 178
kidney	100%	1009.92	89 / 89	97%	13.78	878 / 901
adrenal gland	100%	1341.79	258 / 258	97%	11.90	224 / 230
skin	100%	1512.81	1809 / 1809	94%	15.47	444 / 472
liver	100%	1034.57	226 / 226	92%	7.59	373 / 406
adipose	100%	1585.03	1204 / 1204	0%	0	0 / 0
blood vessel	100%	1867.73	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	17.64	29 / 29
spleen	100%	2313.14	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	16.38	45 / 45
ureter	0%	0	0 / 0	100%	5.12	1 / 1
muscle	99%	982.98	797 / 803	0%	0	0 / 0
heart	98%	795.92	841 / 861	0%	0	0 / 0
peripheral blood	94%	1692.20	875 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	74%	6.51	59 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

GO_0005634	Cellular component	nucleus
GO_0046872	Molecular function	metal ion binding
GO_0051213	Molecular function	dioxygenase activity

Gene name	RSBN1L
Protein name	Round spermatid basic protein 1 like Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein)
Synonyms
Description	FUNCTION: Lysine-specific demethylase that specifically demethylates methylated lysine residues of proteins. .
Accessions	ENST00000334955.13 [Q6PCB5-1] ENST00000445512.5 Q6PCB5 ENST00000441514.1 H7C2D3 ENST00000445288.5 [Q6PCB5-2] C9JM20

RSBN1L report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review